Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

QuantumScape Dropped Below $20 for First Time in 9 Months  

By Will Ashworth, InvestorPlace Contributor

Quantumscape recently dropped below $20 for the first time since November. That’s a long time when you have no revenue. Time to buy QS stock?

Even as It Struggles, Skillz Stock Is Worth Loading up on Here

By Will Ashworth, InvestorPlace Contributor

Skillz lost 28% in the past month. Investors are skeptical about the video-game platform ever making money. Does that make SKLZ stock a sell?  

Atossa Therapeutics Has a Steep Climb Ahead of It

By Will Ashworth, InvestorPlace Contributor

Atossa Therapeutics is popular with the Reddit crowd. However, ATOS stock doesn’t make the top 25 on the platform. Should you buy it anyway? 

7 AI Stocks to Buy as Tesla Doubles Down on Automation

By Will Ashworth, InvestorPlace Contributor

Elon Musk's recent AI Day put the spotlight on automation and artificial intelligence. Here are seven stocks to buy to follow Tesla's lead.

Should Investors Worry a Large Novavax Shareholder Cut Position in Q2?

By Will Ashworth, InvestorPlace Contributor

RA Capital Management is a large Novavax shareholder. It owns 5.1% of NVAX stock. In Q2 2021 it reduced its position slightly. Time to worry?  

Tilray Stock Is a Buy Here, But a Very Frustrating One

By Will Ashworth, InvestorPlace Contributor

The second postponement of Tilray’s special shareholder meeting to vote on issuing more TLRY stock shows why retail investors aren't nirvana.

10 Best Stocks to Buy if ESG Investing Is Your Thing

By Will Ashworth, InvestorPlace Contributor

If you're into ESG investing and are looking for stocks to buy, Morningstar created a portfolio of ESG mutual funds. Here are 10 solid ideas. 

7 Stocks to Buy to Cash In on Activist Investor Engine No. 1’s New ETF 

By Will Ashworth, InvestorPlace Contributor

Engine No. 1 forced Exxon to give the impact investment group at least two seats on its board. Here are 7 stocks to buy from its new ETF. 

Longshot Covid Play Vaxart Stock Is Too Risky at These Prices

By Will Ashworth, InvestorPlace Contributor

Vaxart got approval Aug. 2 for a Phase II trial for its oral Covid-19 vaccine. VXRT stock has gained 22% since. Should you buy on momentum?

Carnival Stock Continues to Carry Weight of the ‘Unwanted’ Passenger

By Will Ashworth, InvestorPlace Contributor

Carnival’s customers are still getting Covid-19 on its ships. That's not good news for CCL stock. At this point, buyers should beware. 

Load More